Crinetics Pharmaceuticals Inc at JPMorgan Healthcare Conference Transcript
Good afternoon everyone. My name is Jessica Fye, Senior Biotech Analyst at J.P. Morgan, and we're continuing the 42 Annual Health Care Conference today with Crinetics. I'm joined by the company's CEO, Scott Struthers. He's going to give a presentation on the business and then we're going to go into Q&A after that, if you want to answer the question in the room, raise your hand and someone will bring you a microphone or alternatively, you can send questions through the portal ad over here. And so with that, let me turn it over to Scott.
&
Thanks, Jess. Good afternoon, everybody. Thanks for having me and thanks for coming. Thanks to those you've supported us through the years. I'll refer you to our forward-looking statements, of course, which I'm sure you have all read carefully.
So since the last time I was here a year ago, we're a very different company. The strategy we've been following since the beginning of the company hasn
Access to All Earning Calls and Stock Analysis | |
30-Year Financial on one screen | |
All-in-one Stock Screener with unlimited filters | |
Customizable Stock Dashboard | |
Real Time Insider Trading Transactions | |
8,000+ Institutional investors’ 13F holdings | |
Powerful Excel Add-in and Google sheets Add-on | |
All data downloadable | |
Quick customer support | |
And much more... |